These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8980756

  • 1. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
    Allen NE, LeTourneau DL, Hobbs JN.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):66-71. PubMed ID: 8980756
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.
    Allen NE, Hobbs JN, Nicas TI.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2356-62. PubMed ID: 8891144
    [Abstract] [Full Text] [Related]

  • 3. Knockout of the two ldh genes has a major impact on peptidoglycan precursor synthesis in Lactobacillus plantarum.
    Ferain T, Hobbs JN, Richardson J, Bernard N, Garmyn D, Hols P, Allen NE, Delcour J.
    J Bacteriol; 1996 Sep; 178(18):5431-7. PubMed ID: 8808932
    [Abstract] [Full Text] [Related]

  • 4. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.
    Billot-Klein D, Gutmann L, Bryant D, Bell D, Van Heijenoort J, Grewal J, Shlaes DM.
    J Bacteriol; 1996 Aug; 178(15):4696-703. PubMed ID: 8755902
    [Abstract] [Full Text] [Related]

  • 5. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
    Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthür M, Donadio S, Walker S, Kahne D.
    J Am Chem Soc; 2005 Mar 16; 127(10):3250-1. PubMed ID: 15755121
    [Abstract] [Full Text] [Related]

  • 6. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Chang JD, Foster EE, Yang H, Kim SJ.
    Biochemistry; 2017 Jan 31; 56(4):612-622. PubMed ID: 28040891
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE, Nicas TI.
    FEMS Microbiol Rev; 2003 Jan 31; 26(5):511-32. PubMed ID: 12586393
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate.
    Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS.
    J Bacteriol; 1994 Jan 31; 176(1):260-4. PubMed ID: 8282706
    [Abstract] [Full Text] [Related]

  • 9. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate.
    Handwerger S, Pucci MJ, Volk KJ, Liu J, Lee MS.
    J Bacteriol; 1992 Sep 31; 174(18):5982-4. PubMed ID: 1522072
    [Abstract] [Full Text] [Related]

  • 10. Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.
    Reynolds PE, Arias CA, Courvalin P.
    Mol Microbiol; 1999 Oct 31; 34(2):341-9. PubMed ID: 10564477
    [Abstract] [Full Text] [Related]

  • 11. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum.
    Billot-Klein D, Gutmann L, Sablé S, Guittet E, van Heijenoort J.
    J Bacteriol; 1994 Apr 31; 176(8):2398-405. PubMed ID: 8157610
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of transglycosylation involved in bacterial peptidoglycan synthesis.
    Goldman RC, Gange D.
    Curr Med Chem; 2000 Aug 31; 7(8):801-20. PubMed ID: 10828288
    [Abstract] [Full Text] [Related]

  • 13. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.
    Rao J, Yan L, Lahiri J, Whitesides GM, Weis RM, Warren HS.
    Chem Biol; 1999 Jun 31; 6(6):353-9. PubMed ID: 10375541
    [Abstract] [Full Text] [Related]

  • 14. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E, Frasch HJ, Kilian R, Pozzi R.
    Int J Med Microbiol; 2015 Feb 31; 305(2):190-5. PubMed ID: 25601631
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA, Fiorini MT, Abell C, Williams DH.
    Bioorg Med Chem; 2000 Nov 31; 8(11):2609-16. PubMed ID: 11092546
    [Abstract] [Full Text] [Related]

  • 18. The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics.
    Allen NE, LeTourneau DL, Hobbs JN.
    J Antibiot (Tokyo); 1997 Aug 31; 50(8):677-84. PubMed ID: 9315081
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics.
    Reynolds PE, Somner EA.
    Drugs Exp Clin Res; 1990 Aug 31; 16(8):385-9. PubMed ID: 2151441
    [Abstract] [Full Text] [Related]

  • 20. Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.
    Billot-Klein D, Gutmann L, Collatz E, van Heijenoort J.
    Antimicrob Agents Chemother; 1992 Jul 31; 36(7):1487-90. PubMed ID: 1510445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.